Q1 Earnings Estimate for AXSM Issued By Leerink Partnrs
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) – Analysts at Leerink Partnrs issued their Q1 2025 EPS estimates for shares of Axsome Therapeutics in a research report issued on Monday, February 10th. Leerink Partnrs analyst M. Goodman forecasts that the company will earn ($1.48) per share for the quarter. The consensus estimate for Axsome Therapeutics’ […]
![Q1 Earnings Estimate for AXSM Issued By Leerink Partnrs](https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/axsome-therapeutics-inc-logo-1200x675.png?v=20240515131110&w=240&h=240&zc=2)